Arthrocart Biotech

Marseille 9e Arrondissement / 11 Boulevard de la Pugette

The French start-up ARTHROCART BIOTECH innovates against osteoarthritis of the knee by developing Collafit®, a patented new generation absorbable colonizable biological meniscal implant. A bio-composite cartilage regeneration material for the treatment of meniscus destruction and severe osteoarthritis of the knee. Research and Development and production of a composite polyurethane meniscal implant and human recombinant collagens expressed by plants, for the treatment of severe osteoarthritis of the knee in active patients. With its unique bio-composite implant technology for the Collafit® meniscal graft, Arthrocart Biotech, based in Marseille - France, offers a disruptive therapeutic approach to address public health issues. The implant allows the regeneration of cartilage in severe osteoarthritis of the knee and avoids the prosthesis in young patients with good physical performance. Objective: to control knee pain with clinical and sports recovery

Business axis :

Medical devices

Category : TPE
Legal form : SAS
Website :
Turnover :

70,000.00 K€